Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry

Fig. 3

Pathway and network analyses of dysregulated proteins. Network and dysregulated pathways of A Gallbladder cancer tissue compared to normal gallbladders. B Gallbladder cancer tissues compared to gallstone tissues. C Gallbladder cancer plasma compared to benign biliary pathologies plasma samples. The colour change is determined by the average Log2 fold change of the protein. D Network analysis shows the intricate relationships between the CDPs. Red and blue indicate downregulated and upregulated proteins in GBC across the groups, respectively

Back to article page